Carlsmed (CARL) Cash & Current Investments (2024 - 2026)

Carlsmed's Cash & Current Investments history runs 3 years deep, the most recent figure standing at $73.1 million for Q1 2026.

• Quarterly Cash & Current Investments rose 68.35% year-over-year to $73.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73.1 million (up 68.35% YoY) and the FY2025 annual result came in at $85.9 million, up 114.06% from the prior year.
• Cash & Current Investments was $73.1 million for Q1 2026 at Carlsmed, down from $85.9 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $115.5 million in Q3 2025 and bottomed at $33.6 million in Q2 2025.
• A 3-year average of $59.3 million and a median of $43.9 million in 2024 frame the typical range for Cash & Current Investments.
• Peak annual rise in Cash & Current Investments reached 159.9% in 2025, while the deepest fall reached 12.0% in 2025.
• Carlsmed's Cash & Current Investments stood at $40.1 million in 2024, then surged by 114.06% to $85.9 million in 2025, then retreated by 14.88% to $73.1 million in 2026.
• Business Quant data shows CARL's Cash & Current Investments at $73.1 million in Q1 2026, $85.9 million in Q4 2025, and $115.5 million in Q3 2025.